[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368755-105":59,"doc-detail-368755-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","s100a14-as-a-potential-biomarker-of-the-colorectal-serrated-neoplasia-pathway","S100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia Pathway","","Accounting for 15–30% of colorectal cancer cases, the serrated pathway remains less characterized than the adenoma–carcinoma sequence. It features sessile serrated lesions as precursors and is marked by BRAF (BRAFV600E), CpG island hypermethylation, and microsatellite instability (MSI). Label-free proteomics showed S100A14 overexpression in sessile serrated lesions versus adenomas and normal tissues, verified by independent immunohistochemical cohorts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/s100a14-as-a-potential-biomarker-of-the-colorectal-serrated-neoplasia-pathway/368755/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/s100a14-as-a-potential-biomarker-of-the-colorectal-serrated-neoplasia-pathway/368755.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the serrated pathway’s significance in colorectal cancer?","Question",{"text":112,"@type":113},"The serrated pathway accounts for about 15–30% of colorectal cancer cases and involves precursor serrated lesions. Tumors are often linked to BRAF mutations, CpG island hypermethylation, and microsatellite instability.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was S100A14 identified in the study?",{"text":117,"@type":113},"Label-free proteomics compared normal margins across several patient groups, revealing significantly increased S100A14 in sessile serrated lesions. This overexpression was then confirmed using immunohistochemical scoring in an independent cohort.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationships did the study find between S100A14 and tumor immunity?",{"text":121,"@type":113},"Single-cell RNA sequencing from the Human Colon Cancer Atlas showed that S100A14 expression in tumor cells positively correlates with tumoral CD8+ cytotoxic T cell abundance. The correlation was especially observed for the CD8+ CXCL13+ subset associated with favorable immunotherapy response.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368755,1790231307,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nS100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia Pathway  \nPierre Adam 1, Catherine Salée 1, Florence Quesada Calvo 1, Arnaud Lavergne 2, Angela-Maria Merli 1, Charlotte Massot 1,3, Noëlla Blétard 4, Joan Somja 4, Dominique Baiwir 5, Gabriel Mazzucchelli 6, Carla Coimbra Marques 7, Philippe Delvenne 4, Edouard Louis 1,3,† and Marie-Alice Meuwis 1,3, *,†  \nAcademic Editor: Carmine Stolfi  \nReceived: 9 July 2025  \nRevised: 23 July 2025  \nAccepted: 28 July 2025  \nPublished: 31 July 2025  \nCitation: Adam, P.; Salée, C.; Quesada Calvo, F.; Lavergne, A.; Merli, A.-M.; Massot, C.; Blétard, N.; Somja, J.; Baiwir, D.; Mazzucchelli, G.; et al. S100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia Pathway. Int. J. Mol. Sci. 2025, 26, 7401 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26157401  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Laboratory of Translational Gastroenterology, GIGA Institute, University of Liège, 4000 Liège, Belgium; [pierre.adam@uliege.be](pierre.adam@uliege.be) (P.A.); [catherine.salee@uliege.be](catherine.salee@uliege.be) (C.S.); [florence.quesadacalvo@hepl.be](florence.quesadacalvo@hepl.be) (F.Q.C.); [angela.maria.merli@gmail.com](angela.maria.merli@gmail.com) (A.-M.M.); [charlotte.massot@chuliege.be](charlotte.massot@chuliege.be) (C.M.); [edouard.louis@uliege.be](edouard.louis@uliege.be) (E.L.)  \n2 GIGA Bioinformatics, GIGA Institute, University of Liège, 4000 Liège, Belgium; [arnaud.lavergne@uliege.be](arnaud.lavergne@uliege.be)  \n[3](3 Hepato-Gastroenterology and Digestive Oncology)[ Hepato-Gastroenterology and Digestive Oncology](3 Hepato-Gastroenterology and Digestive Oncology), [University Hospital of Li](University Hospital of Li)è[ge](ge) ([CHU](CHU)), 4000 Liège, Belgium  \n4 Pathological Anatomy and Cytology, University Hospital of Liège (CHU), 4000 Liège, Belgium; [joan.somja@chuliege.be](joan.somja@chuliege.be) (J.S.); [p.delvenne@uliege.be](p.delvenne@uliege.be) (P.D.)  \n5 GIGA Proteomics, GIGA Institute, University of Liège, 4000 Liège, Belgium; [d.baiwir@uliege.be](d.baiwir@uliege.be)  \n6 Laboratory of Mass Spectrometry, University of Liège, 4000 Liège, Belgium; [gabriel.mazzucchelli@uliege.be](gabriel.mazzucchelli@uliege.be)  \n7 Abdominal Surgery Department, University Hospital of Liège (CHU), 4000 Liège, Belgium; [c.coimbra@chuliege.be](c.coimbra@chuliege.be)  \n* [Correspondence: marie-alice.meuwis@uliege.be](Correspondence: marie-alice.meuwis@uliege.be); Tel.: +32-43662538 † These authors contributed equally to this work.  \nAbstract  \nAccounting for 15–30% of colorectal cancer cases, the serrated pathway remains poorly characterized compared to the adenoma–carcinoma sequence. It involves sessile serrated lesions as precursors and is characterized by BRAF mutations (BRAFV600E ), CpG island hypermethylation, and microsatellite instability (MSI) . Using label-free proteomics, we compared normal tissue margins from patients with diverticular disease, sessile serrated lesions, low-grade adenomas, and high-grade adenomas. We identified S100A14 as significantly overexpressed in sessile serrated lesions compared to low-grade adenomas, high-grade adenomas, and normal tissues. This overexpression was confirmed by immunohistochemical scoring in an independent cohort. Gene expression analyses of public datasets showed higher S100A14 expression in BRAFV600E-mutated and MSI-H colorectal cancers compared to microsatellite stable BRAFwt tumors. This finding was confirmed by immunohistochemical scoring in an independent colorectal cancer cohort. Furthermore, single-cell RNA sequencing analysis from the Human Colon Cancer Atlas reveal","cbCaihSur3iKopV9","https://ap.wps.com/l/cbCaihSur3iKopV9","pdf",7832152,15,"English","# Introduction\n## Colorectal cancer and the serrated pathway\n## Serrated lesion classification and molecular features","[{\"question\":\"What is the serrated pathway’s significance in colorectal cancer?\",\"answer\":\"The serrated pathway accounts for about 15–30% of colorectal cancer cases and involves precursor serrated lesions. Tumors are often linked to BRAF mutations, CpG island hypermethylation, and microsatellite instability.\"},{\"question\":\"How was S100A14 identified in the study?\",\"answer\":\"Label-free proteomics compared normal margins across several patient groups, revealing significantly increased S100A14 in sessile serrated lesions. This overexpression was then confirmed using immunohistochemical scoring in an independent cohort.\"},{\"question\":\"What relationships did the study find between S100A14 and tumor immunity?\",\"answer\":\"Single-cell RNA sequencing from the Human Colon Cancer Atlas showed that S100A14 expression in tumor cells positively correlates with tumoral CD8+ cytotoxic T cell abundance. The correlation was especially observed for the CD8+ CXCL13+ subset associated with favorable immunotherapy response.\"}]","S100A14 as a Potential Biomarker of the Colorectal Serrated Neoplasia Pathway | PDF",1790178368,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3692cbff3f0debd323a90aae94e237b.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/628675ec94fcfe6dc7bbdd72b0036913.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/408bd965e203f45ba82c70065c33d98a.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f6a00df8d0e90b51ae2e229e7133397.webp",980,1385]